Medacta Group SA (MOVE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.172x

Based on the latest financial reports, Medacta Group SA (MOVE) has a cash flow conversion efficiency ratio of 0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF72.95 Million ≈ $92.23 Million USD) by net assets (CHF424.61 Million ≈ $536.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medacta Group SA (MOVE) market capitalisation for the company's overall valuation and market capitalisation.

Medacta Group SA - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Medacta Group SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medacta Group SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medacta Group SA ranked by their cash flow conversion efficiency. Explore MOVE operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
NetScout Systems Inc NASDAQ:NTCT	0.031x
Deppon Logistics Co Ltd SHG:603056	-0.010x
Henan Yuneng Holdings Co Ltd SHE:001896	0.427x
IHS Holding Ltd NYSE:IHS	-8.679x
Anhui Expressway Co Ltd SHG:600012	0.072x
K+S Aktiengesellschaft XETRA:SDF	0.045x
People.Cn Co Ltd SHG:603000	0.020x
Medical Properties Trust Inc NYSE:MPW	-0.016x

Annual Cash Flow Conversion Efficiency for Medacta Group SA (2016–2024)

The table below shows the annual cash flow conversion efficiency of Medacta Group SA from 2016 to 2024. View Medacta Group SA share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF379.66 Million ≈ $480.00 Million	CHF107.14 Million ≈ $135.46 Million	0.282x	+23.97%
2023-12-31	CHF330.04 Million ≈ $417.26 Million	CHF75.13 Million ≈ $94.98 Million	0.228x	-14.95%
2022-12-31	CHF274.65 Million ≈ $347.24 Million	CHF73.51 Million ≈ $92.94 Million	0.268x	+12.08%
2021-12-31	CHF226.40 Million ≈ $286.23 Million	CHF54.06 Million ≈ $68.35 Million	0.239x	-34.00%
2020-12-31	CHF164.72 Million ≈ $208.25 Million	CHF59.59 Million ≈ $75.34 Million	0.362x	+4.57%
2019-12-31	CHF123.23 Million ≈ $155.80 Million	CHF42.63 Million ≈ $53.90 Million	0.346x	-53.60%
2018-12-31	CHF89.07 Million ≈ $112.61 Million	CHF66.41 Million ≈ $83.96 Million	0.746x	+46.94%
2017-12-31	CHF101.67 Million ≈ $128.54 Million	CHF51.59 Million ≈ $65.22 Million	0.507x	+32.33%
2016-12-31	CHF146.87 Million ≈ $185.69 Million	CHF56.31 Million ≈ $71.19 Million	0.383x	--

About Medacta Group SA

SW:MOVE Switzerland Medical Devices

Market Cap

$2.79 Billion

CHF2.21 Billion CHF

Market Cap Rank

#5127 Global

#76 in Switzerland

Share Price

CHF110.60

Change (1 day)

-4.16%

52-Week Range

CHF110.60 - CHF176.00

All Time High

CHF176.00